Periperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease

Autor:	Bruce G. Wolff, John H. Pemberton, William S. Harmsen, Cathy G. Schleck, William J. Sandborn, Jean F. Colombel, William J. Tremaine, Tonia M. Young-Fadok, Edward V. Loftus
Rok vydání:	2003
Předmět:	medicine.medical_specialty Crohn's disease Hepatology business.industry Internal medicine Gastroenterology Medicine business medicine.disease Infliximab medicine.drug Surgery
Zdroj:	Gastroenterology. 124:A521
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(03)82635-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::091b314664ada799ccb462d775594b48 https://doi.org/10.1016/s0016-5085(03)82635-5 Zobrazit plný text záznamu